Evaxion A (EVAX) Profit After Tax (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.68% |
| Dec 31, 2025 | -228.15% |
| Sep 30, 2025 | 195.59% |
| Jun 30, 2025 | -205.76% |
| Mar 31, 2025 | 56.46% |
| Dec 31, 2024 | -87.55% |
| Sep 30, 2024 | 68.78% |
| Jun 30, 2024 | -619.10% |
| Mar 31, 2024 | 126.40% |
| Dec 31, 2023 | 20.34% |
| Sep 30, 2023 | 0.09% |
| Jun 30, 2023 | 8.94% |
| Mar 31, 2023 | 9.18% |
| Dec 31, 2022 | -219.72% |
| Sep 30, 2022 | 220.39% |
| Jun 30, 2022 | -182.33% |
| Mar 31, 2022 | 169.19% |
| Dec 31, 2021 | -59.43% |
| Sep 30, 2021 | 23.01% |
| Jun 30, 2021 | -66.60% |
| Mar 31, 2021 | 4.12% |
| Dec 31, 2020 | -6.46% |
| Sep 30, 2020 | -10.16% |
| Jun 30, 2020 | -17.46% |